Ohio State biotech spinoff targeting MD raises $182M in IPO By: Columbus Business First via Business Journals November 09, 2021 at 06:33 AM EST An Ohio State University spinoff developing treatments for "undruggable" diseases has raised $181.5 million in an IPO. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
